Venture Debt by Startup Stage: Seed to Series C and Beyond

by Cheqly team | | Venture debt by startup stage

When does venture debt become a good option for a startup? The answer can vary as the company evolves from Seed funding to Series A, B, and C. At the same time, these different stages can lead to very different scenarios regarding the company’s capital needs, revenue, financial position, and ability to repay debt. Venture … Continued

ACH Authorization Form: A Complete Guide for Businesses

by Cheqly team | | ACH Authorization Form

Electronic payments have evolved into the primary means of conducting transactions among businesses, vendors, and employees. Nacha reported that B2B ACH payments increased by almost 9.9% in Q2 2026, amounting to 2.2 billion transactions. Such growth is indicative of the significant role ACH is playing in the movement of funds in growing businesses, particularly due … Continued

What Are Net 30 Payment Terms and How They Work for Businesses 

by Cheqly team | | Net 30 Payment terms

For a business owner, waiting to get paid can be one of the toughest parts of running a business. Whether you’re dealing with immediate payments or invoices with trade credit, managing cash flow requires a constant balance between making sales and collecting revenue. One widely used method is Net 30 payment conditions. With such terms, … Continued

How Quickly Should You Update Your 409A After a Funding Round?

by Cheqly team | | 409a Valuation Update Frequency

US venture capital (VC) firms deployed a record $412.7 billion in the first half of 2026, 30% more than the full year 2025 total, though much of that capital was concentrated in large deals. In this active financing environment, a priced round can provide new, market-based information about the value of a company’s securities. If … Continued

Venture Debt for Biotech Startups: Milestones, Risk, and Financing Structure

by Cheqly team | | Venture Debt for Biotech Startups

Biotech venture debt is often used by companies that expect to repay the loan through future equity funding, licensing or partnership income, product sales, or other strategic deals rather than current revenue. Because biotech companies often face long development timelines and uncertain outcomes, lenders structure these facilities to provide needed capital while managing clinical, regulatory, … Continued

Join Cheqly

Never miss any payment or leave your company without an opportunity to keep rolling.

Get Started

Join Cheqly

Never miss any payment or leave your company without an opportunity to keep rolling.

Get Started